Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

MYOMO, INC. (MYO) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/02/2023 144 Form 144 - Report of proposed sale of securities:
08/24/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
08/24/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
08/24/2023 8-K Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive ...
Docs: "Myomo Receives Medicare Part B Reimbursement for First MyoPro® Claims Appropriate payment amounts received on two MyoPro claims; Additional claims are under review while CMS rulemaking to re-classify the MyoPro to the brace benefit category progresses BOSTON ─ Myomo, Inc. , a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it has received payments for two claims submitted for MyoPro® arm braces provided to Medicare fee-for-service beneficiaries. Myomo recently delivered the custom-fabricated MyoPro braces to these two patients. After review of the medical documentation, one of Medicare’s billing contractors, referred to as a DME MAC, has covered and paid for these two..."
08/09/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/09/2023 8-K Quarterly results
Docs: "Myomo Reports Second Quarter 2023 Financial Results Featuring Year Over Year Growth in Revenue and Operating Metrics Q2 revenue of $6.0 million, including license revenue Nearly 1,000 prospective MyoPro® candidates with known payers in the patient pipeline Begins to build Medicare Part B patient pipeline following publication of proposed rule by the Centers for Medicare and Medicaid Services Conference call begins at 4:30 p.m. Eastern time today BOSTON – Myomo, Inc. , a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced financial results for the three and six months ended June 30, 2023. Financial and operational highlights for the second quarter of 2023 include the following : &#x20..."
08/02/2023 144 Form 144 - Report of proposed sale of securities:
07/03/2023 144 Form 144 - Report of proposed sale of securities:
06/28/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
06/12/2023 144 Form 144 - Report of proposed sale of securities:
06/09/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
06/09/2023 144 Form 144 - Report of proposed sale of securities:
05/10/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/10/2023 8-K Quarterly results
Docs: "Myomo Reports First Quarter 2023 Financial Results Featuring 20% Year Over Year Increase in Product Revenue Implementation of virtual waiting room technology enabled a record 438 patients added to the pipeline, up 54% over Q1 2022 Advertising efficiencies resulted in cost per pipeline add of $1,579, down 50% sequentially Conference call begins at 4:30 p.m. Eastern time today BOSTON – Myomo, Inc. , a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced financial results for the three months ended March 31, 2023. Financial and operational highlights for the first quarter of 2023 include the following: • Product revenue was $3.4 million, up 20% compared with the prior year quarter..."
05/03/2023 144 Form 144 - Report of proposed sale of securities:
04/28/2023 ARS Form ARS - Annual Report to Security Holders:
04/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/28/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/28/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
03/13/2023 10-K Annual Report for the period ended December 31, 2022
03/13/2023 8-K Quarterly results
Docs: "Myomo Reports Fourth Quarter and Full Year 2022 Financial Results Fourth quarter revenue was $4.0 million, up 2% sequentially 387 patients added to the pipeline in fourth quarter, up 75% compared with Q4 2021 Conference call begins at 10:00 a.m. Eastern time today BOSTON – Myomo, Inc. , a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced financial results for the three months and full year ended December, 31, 2022. Financial and operational highlights for the fourth quarter of 2022 include the following: • Product and total revenues were $4.0 million, up 2% sequentially and similar to the prior year quarter; • Revenue units were 101, up 16% sequentially and down 6% co..."
02/07/2023 SC 13G/A Must Asset Management Inc. has filed a Schedule 13D for MYOMO, INC.
01/30/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Myomo Appoints Yitzchak Jacobovitz to its Board of Directors BOSTON - Myomo, Inc. , a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of Yitzchak Jacobovitz as a Class II director effective January 27, 2023, to serve until the 2025 annual meeting of stockholders. With this appointment, Myomo has six directors. Mr. Jacobovitz, 47, is a partner and lead healthcare analyst at AIGH Capital Management and affiliates , where he has significantly grown AIGH’s healthcare footprint since joining in 2014. Prior to AIGH, Mr. Jacobovitz was a managing director at Capstone, a policy research firm and an analyst at Leap Tide Capital, a special situations hedge fund. Mr. Jacobov..."
01/20/2023 SC 13G PACKER PAUL reports a 7.2% stake in Myomo, Inc.
01/19/2023 SC 13G HIRSCHMAN ORIN reports a 9.6% stake in MYOMO, INC.
01/17/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
01/17/2023 EFFECT Form EFFECT - Notice of Effectiveness:
01/13/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "NOTICE OF EXERCISE TO: MYOMO, INC. The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant , and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any. Payment shall take the form of : [ ] in lawful money of the United States; or [ ] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2, to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2. Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below: The Warrant Shares shall be deliv...",
"SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT is dated as of January 11, 2023, between Myomo, Inc., a Delaware corporation , and each purchaser identified on the signature pages hereto . WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act , the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement. NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as ...",
"137 Portland St., 4th"
01/13/2023 424B4 Form 424B4 - Prospectus [Rule 424(b)(4)]:
01/11/2023 S-1MEF Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]:
01/10/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Myomo Announces Initiative to Reduce Cash Burn Undertakes a reduction in force to enhance efficiency in its direct billing channel"
01/10/2023 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
01/04/2023 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
12/07/2022 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy